Evidence map›Paper›PMID 41053010›Full record

ArticleCell death & disease2025

Atypical contribution of caspase-3 to melanoma cancer cell motility by regulation of coronin 1B activity.

Kevin Berthenet, Serena Diazzi, Catherine Jamard, Kinga B Stopa, Clara Gil, Stefan Dragan, Deborah Fanfone, Trang Tm Nguyen, Nathalie Al, Francois Virard and 5 more

Abstract read
In one paragraph

Article in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Kevin Berthenet *Cancer Research Centre of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France. kevin.berthenet@lyon.unicancer.fr.
Serena DiazziCancer Research Centre of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France.
Catherine JamardCancer Research Centre of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France.
Kinga B StopaCancer Research Centre of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France.ORCID http://orcid.org/0000-0002-7150-8990
Clara GilCancer Research Centre of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France.ORCID http://orcid.org/0000-0002-3010-3129
Stefan DraganCancer Research Centre of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France.
Deborah FanfoneCancer Research Centre of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France.ORCID http://orcid.org/0000-0002-3909-8143
Trang Tm NguyenCancer Research Centre of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France.
Nathalie AlCancer Research Centre of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France.
Francois VirardCancer Research Centre of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France.ORCID http://orcid.org/0000-0001-7570-1088
Olivier MeuretteCancer Research Centre of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France.ORCID http://orcid.org/0000-0002-1087-5981
Nikolay PopgeorgievCancer Research Centre of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France.
Hector Hernandez-VargasGenomics Consulting, Bron, France.
Julien AblainCancer Research Centre of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France.
Gabriel Ichim *Cancer Research Centre of Lyon (CRCL), INSERM 1052, CNRS, Lyon, France. gabriel.ichim@lyon.unicancer.fr.ORCID http://orcid.org/0000-0002-8386-7405

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies have unveiled unexpected connections between cell death and cell motility. While traditionally recognized for their pro-apoptotic roles, caspases have emerged as regulators of physiological processes beyond cell death, including cellular differentiation and motility. In some particularly aggressive cancers like melanoma, caspase-3, a prominent executioner caspase, is unexpectedly and inexplicably highly expressed. Here, we describe a novel non-apoptotic role for caspase-3 in melanoma cell motility. Through comprehensive molecular and cellular analyses, we demonstrate that caspase-3 is constitutively associated with the cytoskeleton and crucially regulates melanoma cell migration and invasion in vitro and in vivo. Mechanistically, caspase-3 interacts with and modulates the activity of coronin 1B, a key regulator of actin polymerization, thereby promoting melanoma cell motility, independently of its apoptotic protease function. Furthermore, we identify specificity protein 1 (SP1) as a transcriptional regulator of CASP3 expression, and show that its inhibition reduces caspase-3 expression and impairs melanoma cell migration. Overall, this study provides insights into the multifaceted roles of caspase-3 in cancer progression, highlighting its relevance as a novel target for anti-metastatic therapies.

Indexed as

Caspase 3Cell MovementMelanomaMicrofilament ProteinsAnimalsCell Line, TumorGene Expression Regulation, NeoplasticHumansMiceSp1 Transcription FactorCASP3 protein, humanCaspase 3coronin proteinsMicrofilament ProteinsSP1 protein, humanSp1 Transcription Factor

Identifiers

PMID41053010
PMCPMC12500911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.